Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2011 | 03-2010 | 03-2009 | 03-2008 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,582 | -8,057 | -6,605 | -10,914 | -11,162 |
| Depreciation Amortization | 484 | 509 | 501 | 414 | 409 |
| Accounts receivable | -167 | -395 | 144 | 67 | -216 |
| Other Working Capital | 660 | 93 | 642 | -1,993 | -888 |
| Other Operating Activity | 14,158 | 6,486 | 778 | 2,591 | 3,695 |
| Operating Cash Flow | $1,553 | $-1,365 | $-4,540 | $-9,834 | $-8,162 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -492 | N/A | -46 | -520 | -958 |
| Purchase Of Investment | N/A | N/A | N/A | -4,992 | -2,010 |
| Purchase Sale Intangibles | -866 | -96 | N/A | N/A | -6 |
| Other Investing Activity | -863 | -64 | 105 | -17 | 1,169 |
| Investing Cash Flow | $-1,355 | $-64 | $59 | $-5,530 | $-1,799 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 58 | N/A |
| Debt Repayment | N/A | -210 | -200 | -191 | -175 |
| Common Stock Issued | N/A | N/A | N/A | 375 | 2,089 |
| Dividend Paid | N/A | N/A | -163 | -411 | -34 |
| Other Financing Activity | 1,049 | 1,934 | 1,425 | 18,424 | -26 |
| Financing Cash Flow | $1,049 | $1,724 | $1,061 | $18,255 | $1,853 |
| Beginning Cash Position | 578 | 283 | 3,703 | 812 | 8,919 |
| End Cash Position | 1,826 | 578 | 283 | 3,703 | 812 |
| Net Cash Flow | $1,248 | $296 | $-3,420 | $2,891 | $-8,108 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,553 | -1,365 | -4,540 | -9,834 | -8,162 |
| Capital Expenditure | -522 | N/A | -46 | -520 | -958 |
| Free Cash Flow | 1,031 | -1,365 | -4,586 | -10,355 | -9,120 |